4.4 Article

Persistent HIV transcription and variable antiretroviral drug penetration in lymph nodes during plasma viral suppression

期刊

AIDS
卷 36, 期 7, 页码 985-990

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAD.0000000000003201

关键词

HIV; lymphoid tissues; pharmacokinetics; transcription

资金

  1. National Institute of Allergy and Infectious Diseases [R01 AI-124965, R01 AI-125127]
  2. ViiV Healthcare
  3. Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [WW81XWH-18-2-0040]
  4. U.S. Department of Defense (DOD) [WW81XWH-18-2-0040]
  5. Thai Red Cross AIDS Research Centre
  6. Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institute of Health (DAIDS, NIAID, NIH) [AAI20052001]
  7. Thai Government Pharmaceutical Organization
  8. Gilead Sciences
  9. Merck

向作者/读者索取更多资源

The study evaluated the impact of antiretroviral drug concentrations in lymph nodes on HIV transcription, indicating that certain drugs, such as maraviroc, may contribute to more complete viral suppression in lymph nodes.
Objective: The ability of antiretroviral drugs to penetrate and suppress viral replication in tissue reservoir sites is critical for HIV remission. We evaluated antiretroviral concentrations in lymph nodes and their impact on HIV transcription. Methods: Participants of the RV254/SEARCH010 Acute HIV Infection Cohort in Thailand were enrolled. Group 1 (n = 6) initiated and continued antiretrovirals with two nucleoside reverse transcriptase inhibitors (NRTIs), dolutegravir (DTG) and mar- aviroc (MVC). Group 2 (n = 12) initiated antiretrovirals with two NRTIs as well as efavirenz and were switched to two NRTIs as well as DTG. Antiretroviral concentrations were measured by mass spectroscopy. HIV RNA+ and DNA+ cells were measured by in-situ hybridization. Results: All participants were MSM. At lymph node biopsy, all had plasma HIV RNA less than 20 copies/ml. Group 2 had longer durations of antiretroviral and DTG use (medians of 135 and 63 weeks, respectively) compared with Group 1 (median 44 weeks for both). TFV-DP, 3TC-TP, DTG and MVC were quantifiable in all lymph node samples from participants receiving those drugs versus carbovir-triphosphate (CBV-TP) in four out of 14. Median ratios of lymph node to peripheral blood concentrations were DTG, 0.014; MVC, 6.9; CBV-TP, 0.38; 3TC-TP, 0.32; and TFV-DP, 3.78. Median inhibitory quotients [ratios of lymph node concentrations to in-vitro inhibitory levels (IC50-or-90)] were DTG, 0.8; MVC, 38.8; CBV-TP, 0.5; 3TC- TP, 4.1; and TFV-DP, 1.8. Ongoing viral transcription was detected in lymph node of all participants. Median lymph node RNA+ cells were 71 350 versus 99 750 cells/g for Groups 1 and 2, respectively (P = 0.111). Conclusion: MVC has enhanced lymph node penetration and thereby may contribute to more complete viral suppression in the lymph node.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

T cell migration potentiates HIV infection by enhancing viral fusion and integration

Paul Lopez, Oluwaseun Ajibola, Amelie Pagliuzza, Romaniya Zayats, Wan Hon Koh, Alon Herschhorn, Nicolas Chomont, Thomas T. Murooka

Summary: The migration of T cells in 3D collagen matrix enhances HIV infection and integration. Migratory T cells are less sensitive to antiretroviral drugs and can freely migrate into regions with high HIV densities, resulting in high infection rates. These findings indicate that the environmental context of initial HIV-T cell encounters modulates HIV-1 entry and integration efficiencies.

CELL REPORTS (2022)

Article Immunology

Willingness of Older Canadians with HIV to Participate in HIV Cure Research Near and After the End of Life: A Mixed-Method Study

David Lessard, Karine Dube, Martin Bilodeau, Patrick Keeler, Shari Margolese, Ron Rosenes, Liliya Sinyavskaya, Madeleine Durand, Erika Benko, Colin Kovacs, Charlotte Guerlotte, Wangari Tharao, Keresa Arnold, Renee Masching, Darien Taylor, Jose Sousa, Mario Ostrowski, Jeff Taylor, Andy Kaytes, Davey Smith, Sara Gianella, Nicolas Chomont, Jonathan B. Angel, Jean-Pierre Routy, Eric A. Cohen, Bertrand Lebouche, Cecilia T. Costiniuk

Summary: This study explores the willingness of older people with HIV (PWHIV) to participate in HIV cure research at the end of life. The results indicate that most participants are willing to participate in research autopsy, HIV biobanking, and hypothetical medical studies, mainly for altruistic purposes. However, a dialogue should be initiated to provide necessary information, address concerns, and accommodate their needs and preferences.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2022)

Article Immunology

Association Between the Development of Subclinical Cardiovascular Disease and Human Immunodeficiency Virus (HIV) Reservoir Markers in People With HIV on Suppressive Antiretroviral Therapy

Isabelle Turcotte, Mohamed El-Far, Manel Sadouni, Carl Chartrand-Lefebvre, Ali Filali-Mouhim, Remi Fromentin, Annie Chamberland, Mohammad-Ali Jenabian, Jean-Guy Baril, Benoit Trottier, Rejean Thomas, Cecile L. Tremblay, Madeleine Durand, Nicolas Chomont, Canadian HIV Aging Cohort Study

Summary: People with HIV diagnosed with atherosclerotic plaques have higher levels of HIV DNA compared to those without plaques. In a prediction model with 27 traditional and HIV-related risk factors, measures of HIV DNA were found to be among the most important predictors of plaque formation.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

HIV rapidly targets a diverse pool of CD4+T cells to establish productive and latent infections

Pierre Gantner, Supranee Buranapraditkun, Amelie Pagliuzza, Caroline Dufour, Marion Pardons, Julie L. Mitchell, Eugene Kroon, Carlo Sacdalan, Nicha Tulmethakaan, Suteeraporn Pinyakorn, Merlin L. Robb, Nittaya Phanuphak, Jintanat Ananworanich, Denise Hsu, Sandhya Vasan, Lydie Trautmann, Remi Fromentin, Nicolas Chomont

Summary: During early stages of HIV infection, the virus initially targets a small population of proliferating memory CD4+ T cells with high surface expression of CCR5. Productively infected cells exhibit different phenotypes and TCR sequences depending on the stage of infection and location within the body. The TCR repertoire of infected cells is biased towards previously expanded and disseminated clones, suggesting independent infection events. Latent genetically intact proviruses are present early in infection, indicating simultaneous generation of latent infected cells.

IMMUNITY (2023)

Article Virology

HIV-1 DNA and Immune Activation Levels Differ for Long-Lived T-Cells in Lymph Nodes, Compared with Peripheral Blood, during Antiretroviral Therapy

Christina Mallarino-Haeger, Maria Pino, Elise G. Viox, Amelie Pagliuzza, Colin T. King, Kevin Nguyen, Justin L. Harper, Sol del Mar Aldrete, Barbara Cervasi, Keith A. Delman, Michael C. Lowe, Nicolas Chomont, Vincent C. Marconi, Mirko Paiardini

Summary: Understanding the contributions of different T-cell subsets to the persistence and localization of the HIV reservoir is crucial for developing cure interventions. This study compared the levels of T-cell activation and the size of the HIV reservoir in blood, rectal tissue, and lymph nodes, and found that certain T-cell subsets had higher levels of HIV DNA and immune activation in lymph nodes compared to blood.

JOURNAL OF VIROLOGY (2023)

Article Multidisciplinary Sciences

Phenotypic characterization of single CD4+T cells harboring genetically intact and inducible HIV genomes

Caroline Dufour, Corentin Richard, Marion Pardons, Marta Massanella, Antoine Ackaoui, Ben Murrell, Bertrand Routy, Rejean Thomas, Jean-Pierre Routy, Remi Fromentin, Nicolas Chomont

Summary: The phenotypic diversity of HIV-infected cells persisting during antiretroviral therapies (ART) was investigated. CD4+ T cells expressing integrin VLA-4 were found to be enriched in replication-competent HIV. Clonally expanded cells with identical proviruses displayed diverse phenotypes, indicating the role of cellular proliferation in the phenotypic diversification of the HIV reservoir. Genetically intact and inducible viral genomes were associated with higher levels of VLA-4 expression in CD4+ T cells. Replication-competent HIV was highly enriched in memory CD4+ T cells expressing high levels of VLA-4.

NATURE COMMUNICATIONS (2023)

Article Immunology

Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy

Chris Y. Y. Chiu, Maya D. D. Schou, James H. H. McMahon, Steven G. G. Deeks, Remi Fromentin, Nicolas Chomont, Michelle N. N. Wykes, Thomas A. A. Rasmussen, Sharon R. R. Lewin

Summary: The expression of immune checkpoint proteins is elevated in people with HIV, both on and off antiretroviral therapy (ART). Soluble immune checkpoint proteins and their ligands can be detected in plasma and may correlate with HIV reservoir size and T-cell function. Further investigation is needed to understand the role of these soluble proteins in the treatment and cure of HIV infection.

FRONTIERS IN IMMUNOLOGY (2023)

Article Medicine, General & Internal

Primary role of type I interferons for the induction of functionally optimal antigen-specific CD8+ T cells in HIV infection

Mariela P. Cabral-Piccin, Laura Papagno, Xavier Lahaye, Federico Perdomo-Celis, Stevenn Volant, Eoghann White, Sian Llewellyn-Lacey, David A. Price, Nicolas Chomont, Nicolas Manel, Asier Saez-Cirion, Victor Appay

Summary: HIV-2 primes CD8+ T cells with potent antiviral functionality by activating the cGAS/STING pathway, resulting in enhanced immune control of HIV-1. The use of cGAMP or other STING agonists can enhance CD8+ T cell-mediated immune responses against HIV-1, providing a new direction for HIV-1 therapy.

EBIOMEDICINE (2023)

Article Microbiology

Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV CD4+ and CD8+ T cells

Mathieu Dube, Olivier Tastet, Caroline Dufour, Geremy Sannier, Nathalie Brassard, Gloria-Gabrielle Delgado, Amelie Pagliuzza, Corentin Richard, Manon Nayrac, Jean-Pierre Routy, Alexandre Prat, Jacob D. Estes, Remi Fromentin, Nicolas Chomont, Daniel E. Kaufmann

Summary: During suppressive antiretroviral therapy, spontaneous transcription and translation of HIV can persist, with p24(-)expressing cells evident in 39% of participants. Active reservoirs are enriched in central memory T cells and CCR6(-) and activation marker-expressing cells. The magnitude of the active reservoir positively correlates with HIV-specific CD4(+) and CD8(+) T cell responses and multiple HIV-specific T cell clusters.

CELL HOST & MICROBE (2023)

Article Microbiology

An active HIV reservoir during ART is associated with maintenance of HIV-specific CD8+T cell magnitude and short-lived differentiation status

Hiroshi Takata, Julie L. Mitchell, Julian Pacheco, Amelie Pagliuzza, Suteeraporn Pinyakorn, Supranee Buranapraditkun, Carlo Sacdalan, Louise Leyre, Sam Nathanson, Juyeon C. Kakazu, Jintana Intasan, Peeriya Prueksakaew, Nitiya Chomchey, Nittaya Phanuphak, Mark de Souza, Elias K. Haddad, Morgane Rolland, Sodsai Tovanabutra, Sandhya Vasan, Denise C. Hsu, Nicolas Chomont, Lydie Trautmann

Summary: This study found that HIV-specific CD8+ T cell responses and HIV reservoir declined significantly after 2 years of antiretroviral therapy (ART). Sustained HIV-specific CD8+ T cell responses were associated with a greater reduction of integrated HIV provirus. However, the magnitude of CD8+ T cells specific for different HIV proteins positively correlated with the active reservoir size during ART. High HIV DNA levels were strongly associated with maintenance of short-lived HIV-specific CD8+ T cells regardless of the time of ART initiation.

CELL HOST & MICROBE (2023)

Article Cell Biology

Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ART

Caroline Dufour, Maria Julia Ruiz, Amelie Pagliuzza, Corentin Richard, Aniqa Shahid, Remi Fromentin, Rosalie Ponte, Amelie Cattin, Tomas Raul Wiche Salinas, Syim Salahuddin, Teslin Sandstrom, Stephanie Burke Schinkel, Cecilia T. Costiniuk, Mohammad-Ali Jenabian, Petronela Ancuta, Jean-Pierre Routy, Eric A. Cohen, Zabrina L. Brumme, Christopher Power, Jonathan B. Angel, Nicolas Chomont

Summary: HIV persists in various tissues during antiretroviral therapy, with different anatomical compartments contributing differently to the viral reservoir. In two individuals on suppressive ART, HIV DNA was found in all tissues, with significant variations across compartments. Intact HIV genomes were mainly detected in secondary lymphoid organs, indicating the potential migration and circulation of infected cells between anatomical sites.

CELL REPORTS (2023)

Article Microbiology

CD8+cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+Mauritian cynomolgus macaques initiated on ART two weeks post-infection

Olivia E. Harwood, Lea M. Matschke, Ryan V. Moriarty, Alexis J. Balgeman, Abigail J. Weaver, Amy L. Ellis-Connell, Andrea M. Weiler, Lee C. Winchester, Courtney V. Fletcher, Thomas C. Friedrich, Brandon F. Keele, David H. O'Connor, Jessica D. Lang, Matthew R. Reynolds, Shelby L. O'Connor

Summary: Persistent post-treatment control of HIV was observed in Mauritian cynomolgus macaques, indicating that small viral reservoirs and immune-mediated virus suppression play a role in this phenomenon. This model can help further understand the mechanisms behind post-treatment control and identify potential therapeutic targets for inducing durable HIV remission in humans.

PLOS PATHOGENS (2023)

Article Cell Biology

Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial

Ralph-Sydney Mboumba Bouassa, Eve Comeau, Yulia Alexandrova, Amelie Pagliuzza, Alexis Yero, Suzanne Samarani, Judy Needham, Joel Singer, Terry Lee, Florian Bobeuf, Claude Vertzagias, Giada Sebastiani, Shari Margolese, Enrico Mandarino, Marina B. Klein, Bertrand Lebouche, Jean-Pierre Routy, Nicolas Chomont, Cecilia T. Costiniuk, Mohammad-Ali Jenabian

Summary: Chronic HIV infection is accompanied by persistent inflammation, and this study suggests that cannabinoids may help reduce systemic inflammation in people with HIV. The study found that oral cannabinoids, either in combination with THC and CBD or CBD-only, significantly reduced inflammatory markers and affected immune cell subsets. These findings can guide future large clinical trials investigating the anti-inflammatory properties of cannabinoids.
Article Medicine, General & Internal

Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study

Lena Royston, Stephane Isnard, Carolina A. Berini, Simeng Bu, Peter L. Lakatos, Talat Bessissow, Nicolas Chomont, Marina Klein, Bertrand Lebouche, Alexandra de Pokomandy, Nadine Kronfli, Cecilia T. Costiniuk, Rejean Thomas, Cecile Tremblay, Guy Boivin, Jean-Pierre Routy

Summary: This study aims to assess whether letermovir, a novel anti-CMV drug, can inhibit CMV subclinical replication in HIV patients receiving ART, and subsequently reduce CMV-associated gut damage and inflammation. The study will conduct a 14-week open-label, randomized, controlled clinical trial with 60 CMV-seropositive ART-treated HIV patients. The effects of letermovir on gut damage, microbial translocation, inflammation, and HIV reservoir size will be evaluated.

BMJ OPEN (2023)

Article Immunology

Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia

Mehdi Benlarbi, Jonathan Richard, Catherine Bourassa, William D. Tolbert, Carl Chartrand-Lefebvre, Gabrielle Gendron-Lepage, Mohamed Sylla, Mohamed El-Far, Marc Messier-Peet, Camille Guertin, Isabelle Turcotte, Remi Fromentin, Myriam Maude Verly, Jeremie Prevost, Andrew Clark, Walther Mothes, Daniel E. Kaufmann, Frank Maldarelli, Nicolas Chomont, Philippe Begin, Cecile Tremblay, Jean-Guy Baril, Benoit Trottier, Sylvie Trottier, Ralf Duerr, Marzena Pazgier, Madeleine Durand, Andres Finzi

Summary: This study found that soluble glycoprotein 120 (sgp120) and gp120-specific anti-cluster A antibodies are associated with immune dysfunction, chronic inflammation, and subclinical cardiovascular disease in HIV-infected individuals.

JOURNAL OF INFECTIOUS DISEASES (2023)

暂无数据